The nurse is caring for a client receiving ciprofloxacin for treatment of a urinary tract infection (UTI). The nurse will include which black box warning (BBW) in the discharge education?
This medication can cause thromboembolic events
This drug has a black box warning for causing tendon rupture
This medication can cause endometrial cancers
This medication can cause breast cancer
The Correct Answer is B
A. Thromboembolic events: This is not a black box warning for ciprofloxacin.
B. This drug has a black box warning for causing tendon rupture: Ciprofloxacin, a fluoroquinolone, has a black box warning for the risk of tendonitis and tendon rupture, especially in older adults or those on corticosteroids.
C. Endometrial cancers: Ciprofloxacin is not associated with cancer.
D. Breast cancer: There is no link between ciprofloxacin and breast cancer.
Free Nursing Test Bank
- Free Pharmacology Quiz 1
- Free Medical-Surgical Quiz 2
- Free Fundamentals Quiz 3
- Free Maternal-Newborn Quiz 4
- Free Anatomy and Physiology Quiz 5
- Free Obstetrics and Pediatrics Quiz 6
- Free Fluid and Electrolytes Quiz 7
- Free Community Health Quiz 8
- Free Promoting Health across the Lifespan Quiz 9
- Free Multidimensional Care Quiz 10
View Related questions
Correct Answer is D
Explanation
A. Regular sun exposure is needed to maximize drug efficacy: This is incorrect; in fact, doxycycline can cause photosensitivity, and sun exposure should be minimized.
B. Avoid water while taking this medication: Water should be taken with doxycycline to help prevent esophageal irritation.
C. Take this medication with antacids to relieve gastrointestinal symptoms: Antacids can also interfere with doxycycline absorption, so they should be avoided.
D. Avoid dairy products when taking this medication: Dairy products can bind to doxycycline and reduce its absorption in the gastrointestinal tract, which decreases its effectiveness. The client should avoid dairy when taking the medication.
Correct Answer is B
Explanation
A. Clotting Factors: Epoetin alfa does not directly influence clotting factors.
B. Hemoglobin & hematocrit: Epoetin alfa is used to stimulate red blood cell production, which increases hemoglobin and hematocrit levels. Monitoring these values helps determine the drug’s therapeutic effectiveness in improving anemia associated with chronic renal disease.
C. Leukocyte Count: This medication primarily affects red blood cells, not white blood cells (leukocytes).
D. ALT & AST: These are liver function tests and are not related to the therapeutic effect of epoetin alfa.